Extrait

Background and study aims: Improving the quality of care for people with vascular conditions is a global priority. For example, primary care has an important role in identifying and managing people with chronic kidney disease (CKD). CKD is common but often unrecognised as there are no symptoms in the early stages of the disease. It is usually associated with other conditions, such as hypertension (high blood pressure), diabetes and cardiovascular disease. Early recognition and treatment of CKD, aimed at reducing blood pressure can prevent or delay the progression of CKD and reduce the risk of cardiovascular disease. However, patients report a lack of awareness of the condition and there are concerns by GPs and nurses over the lack of appropriate information. This results in missed opportunities to support people diagnosed with CKD. To prevent or delay future health problems, there are actions people with kidney problems can take. The BRIGHT study aims to improve understanding and support for people with kidney problems by providing self-help information and improve access to local support services. Who can participate? Adult patients registered in general practices in Greater Manchester who have a diagnosis of stage 3 chronic kidney disease. What does the study involve? Participants will be randomly split into two groups: Group 1: will be given a kidney information guidebook followed by a telephone call from a support worker who will talk to participants about local support services for people with health problems. Details of a website linking participants to these services will also be provided Group 2: will be given a kidney information guidebook six months after this face-to-face meeting. At the start of the study and then six months later, we will ask participants to complete a questionnaire. We will also ask participants' GPs to send us details of participants' blood pressure readings, taken at the start of the study and at six months. What are the possible benefits and risks of participating? There is potential that information about chronic kidney disease may cause distress for participants. However, both the intervention and the study trial have been designed to address this issue. Although we cannot promise any direct benefit for participants, we believe that involvement in the study might help improve benefit for the way services are provided to NHS patients in the future. Where is the study run from? The Health Sciences Research Group at The University of Manchester. When is study starting and how long is it expected to run for? We are recruiting participants between April and November 2012. A written report of the study is likely to be available by December 2013. This will be provided to participants' general practices and will be also be available on the CLAHRC for Greater Manchester website at http://clahrc-gm.nihr.ac.uk /. Who is funding the study? NIHR CLAHRC for Greater Manchester ( http://clahrc-gm.nihr.ac.uk /) Who is the main contact? Dr Tom Blakeman [email protected]

Critère d'inclusion

• chronic kidney disease

Liens

• isrctn
• ictrp